Our Mission: Optimizing the standard of wound care through innovations grounded in science, compassion, and collaboration.

Our Vision: Raising the standard of caring.

Awards

2021
BioScience Company of the year

2019 Technology Elite Awards - Most Innovative Regenerative Medicine, Biotech Company

Phoenix Business Journal 2020 Small Business Awards Small Category

Reuters Pharma Entrepreneur Award: Patient Solution

Origin Story

"Before co-founding BioLab Holdings I had a long and successful career in the telecommunications industry. At the age of 50, I decided to return to school to get my executive MBA to sharpen my skills and fill any knowledge gaps I had. It proved very impactful, as it allowed me to see other people at different stages in their careers, and what some of them were achieving or not achieving. It made me reflect internally on what I was doing and how I was using my skills.

On my last day of grad school, I had a life-altering moment — a rollover car accident from which I miraculously walked away without a scratch. The next day I was on a plane to Rochester, New York to start a new position and couldn’t help but wonder, “Am I really doing anything to help improve lives or to help others?”. And the answer — painfully — was no. I was helping businesses become more efficient, but I really wasn’t changing lives.

I wanted to create value for other human beings. So, I made a career shift from software sales to regenerative medicine. Yes, it was a big transition, but we are so fortunate today to have a wealth of information at our fingertips. You truly can learn to do anything new you want.

It’s been a great journey to where I am now. Regenerative medicine has come a long way in five years, and I think it’s going to keep progressing tremendously as we learn more about how the body can help heal itself. This path is enabling me to help people who are suffering from hard-to-heal wounds. We’re helping save people’s limbs. We’re absolutely changing lives and improving the quality of it for countless individuals. For me, this line of work definitely feels much better than saving a company money or helping a company achieve a better business plan."

-Bob Maguire, Chairman of the Board

Leadership Team

Bob Maguire
Chairman of the Board

Bob Maguire is the Founder and Chairman of the Board of BioLab Holdings. With more than 30 years’ experience in leadership, operations, and sales management, Bob oversees the product strategy and vision for the company. Bob founded BioLab Holdings after surviving a life-altering moment, in which he realized he wanted to do more to help people and leave a lasting impact.

After years of research and identifying how many individuals suffer from chronic health, pain and wound issues, he was determined to find a solution. Years of research combined with his prior experience leading a biotech company that was focused on research and collaboration with top universities and hospitals have culminated in the formation of BioLab Sciences.

Today, Bob and his team are on a mission to uncover how the body’s own cells and tissues can be used to improve quality of life for people around the world. Bob holds a Bachelor of Science in business from Manhattan College and an executive masters in business administration from Arizona State University, W.P. Carey School of Business

Jaime Leija
President / Chief Executive Officer

Jaime Leija is a co-founder and President of BioLab Holdings, Jaime Leija is responsible for bringing the company’s revolutionary regenerative medicine products to market. With more than 20 years’ experience and an extensive background in sales leadership, marketing and operations, Jaime works to commercialize innovative products and technologies that will benefit orthopedic, wound care, and pain management industries.

Prior to BioLab Holdings, Jaime was the region vice president of sales for IKON Office Solutions, AOT-Xerox and Advance Laboratory Consultants. He has a bachelor of science in business and an executive masters in business administration from Arizona State University W.P. Carey School of Business.

Scott Swonger
Chief Financial Officer

Scott Swonger, CFO of BioLab Holdings has spent the last 30 years as a financial management leader for health, technology and environmental companies. At BioLab Sciences, he provides leadership related to growth strategy, contract management, overseeing new market development and partnership cultivation.

Prior to BioLab Holdings, he held executive-level finance positions at companies including Redirect Health, Grand Lake Foot and Ankle, and Beacon Medical Billing Services and was a founder and senior manager of a national specialty contracting and logistics company. Scott has a Bachelor of Science in business administration and international finance from Miami University.

Carlos Encinas, PhD
Chief Science Officer

Dr. Carlos Encinas is a Technology Management and Commercialization Expert focusing in Life Sciences. Carlos currently serves as the Chief Science Officer at BioLab Holdings, a Biotech Start-Up Company based in Mesa Arizona focusing on regenerative medicine. He is responsible for the identification, evaluation, and commercialization of the Company's intellectual property and strategic partnerships. Carlos also supports product development and evaluates avenues for commercialization overseas.

Dr. Encinas is also a founder of a biotechnology company (AmerStem), focusing on utilizing cell culture techniques to develop what AmerStem calls, Agriculture 2.0. Dr. Encinas recently served as a Director for Business Development and International Relations for Skysong Innovations, the Technology Transfer company for Arizona State University (ASU). He also served as the Director for the Office of Industry Research and Collaborations at ASU. He previously served as the Director of the Cedars-Sinai Medical Center and Dignity Health’s Technology Transfer Office, providing support for the protection and commercialization of intellectual property from at the Medical Center and other research institutes and universities, both domestic and foreign.

Dr. Encinas has served several different leadership positions in a variety of technology-based companies, primarily in the Life Sciences and Green Technologies realm. His experience includes CFO, COO, CSO, senior management and advisory role for start-ups in the US, Europe and South America. Carlos’ role has been to support, mentor and advise early-stage and technology-based companies around the globe, while maintaining a sustainable and clean strategies. Carlos has a passion for creating and developing international networks. He has a PhD in Molecular Biology from the University of Arizona as well as a masters in Business Administration.

Marshall Medley, DO, FACOS, CWS-P
Chief Medical Officer

Marshall Medley, DO, FACOS, CWS-P, Chief Medical Officer for BioLab Holdings is board certified in vascular surgery and has dealt with acute and chronic wounds for 20 years. His surgical experience has exposed him to many different wounds and wound pathologies. He has served as a medical director for two different wound care and hyperbaric oxygen centers over his career.

His role at BioLab Holdings is to assist with development of new products, generate protocols and indications for products, and train clinicians and the sales force in the use and application of these products. His goal is to get the products in the hands of the clinicians to help them help the patients heal. Having practiced in wound care for many years, it is his goal to help others be successful and help these patients get on with their lives.

Prior to his work at BioLab Holdings, he was in private and employed practice in vascular surgery and wound care in several hospitals in southeast Michigan. He now resides in Utah and travels to meet clinicians and others about these products. His bachelors degree in Biology is from California State University at San Bernardino, a Doctor of Osteopathic Medicine degree from Western University of Health Sciences in Pomona, CA, General Surgery Residency through Michigan State University, and a vascular surgery fellowship in Dayton, OH through Ohio University and Grandview Hospital and Medical Center.

Marty Kuser

Chief Commercialization Officer

Marty Kuser is the Chief Commercialization Officer of BioLab Holdings, Marty is responsible for introducing innovative regenerative medicine products and technologies that will benefit the orthopedic, wound care, and pain management industries. Marty has over 25 years of experience in the medical device sector, with an additional 15 years in sales leadership, and 10 years dedicated to human tissue and regenerative medicine.

Prior to BioLab Holdings, Marty was the VP of Sales at Aziyo Biologics, and has held leadership positions at Xtant Medical, Bone Bank Allografts, and multiple medical device companies. He has a BBA in Marketing from Loyola University of Maryland.